Nov. 20 at 7:47 AM
$KPRX "Kiora ended the third quarter of 2025 with
$19.4 million in cash, cash equivalents, and short-term investments." MC is still about 7 million, management makes a good job it seems. But you can manipulate sp by low volume. That is crazy imo! I'm invested and every time the question with smal biotechs: hold or sell and buy back later? Not sure, may be I stay and sit it out! Can't deny the facts that cash is three times of MC and management works economically. GL
